A carregar...
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model
PURPOSE: The purpose of these Phase III studies was to evaluate the efficacy and safety of cetirizine ophthalmic solution 0.24% compared with vehicle in the treatment of allergen-induced conjunctivitis using the Ora conjunctival allergen challenge (CAC)(®) model. METHODS: The single-center (Study 1)...
Na minha lista:
| Publicado no: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296187/ https://ncbi.nlm.nih.gov/pubmed/30587908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S185835 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|